Tag: Stellest

Myopia management is transforming pediatric eye care, but myths surrounding genetics, screen time, contact lenses, and treatment effectiveness continue to create barriers to early intervention. In this MythBusters edition, Dr. Jennifer Lyerly and Dr. Justin Kwan separate fact from fiction while exploring the latest evidence behind myopia control and practical strategies every eye care professional can use to protect children's long-term vision.

Myopia control with Stellest glasses helps slow down nearsightedness in children using an FDA-approved lens technology. Designed for everyday wear, Stellest offers a simple and effective way to protect your child’s vision and reduce the risk of future eye health complications.

EssilorLuxottica today announced the U.S. Food and Drug Administration (FDA) has granted market authorization for its Essilor Stellest lens using the De Novo pathway. This follows the product’s earlier recognition with the FDA granting designation as a Breakthrough Device in 2021. The Essilor Stellest lens is the first-ever FDA market authorized spectacle lens clinically proven to slow myopia progression in children1,2.